Nitrofurantoin |
Formulary
|
|
MHRA Drug Safety Update (April 2023): Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions MHRA Drug Safety Update (Feb 2015): Nitrofurantoin now contraindicated in most patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 |
|